Search

Search Results
Results 601 - 610 of 648 for kidney stones
  • Ozempic
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Ozempic intended for persons living in Australia.
  • Mesalazine 1.2 TAKEDA
    Drug - 17 Jul 2025
    Consumer Medicine Information (CMI) about Mesalazine 1.2 TAKEDA intended for persons living in Australia.
  • Mezavant
    Drug - 15 Jul 2025
    Consumer Medicine Information (CMI) about Mezavant intended for persons living in Australia.
  • Saxenda
    Drug - 10 Jan 2025
    Consumer Medicine Information (CMI) about Saxenda intended for persons living in Australia.
  • DBL Vinblastine
    Drug - 24 Dec 2024
    Consumer Medicine Information (CMI) about DBL Vinblastine intended for persons living in Australia.
  • Fisamox
    Drug - 20 Dec 2024
    Consumer Medicine Information (CMI) about Fisamox intended for persons living in Australia.
  • Lipigem
    Drug - 5 Nov 2024
    Consumer Medicine Information (CMI) about Lipigem intended for persons living in Australia.
  • DBL Sulfamethoxazole and Trimethoprim
    Drug - 1 Oct 2024
    Consumer Medicine Information (CMI) about DBL Sulfamethoxazole and Trimethoprim intended for persons living in Australia.
  • D-Penamine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about D-Penamine intended for persons living in Australia.
  • Hyperparathyroidism Symptoms
    Health - 1 Jul 2023
    Hyperparathyroidism does not always cause symptoms and treatment may not be necessary. In these cases, regular monitoring and a diet containing a balanced amount of calcium may be all that is...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback